Proton pump inhibitors in gastroesophageal reflux disease: "a custom-tailored therapeutic regimen".

Abstract

The Montreal Definition and Classification divides Gastroesophageal Reflux Disease (GERD) into esophageal symptomatic syndromes (and with mucosal damage) and extraesophageal syndromes (with acid established association and proposed association). In typical GERD symptoms, an 8-week treatment with PPIs is satisfactory in most cases (> 90%). Response rates to… (More)

Topics

5 Figures and Tables

Cite this paper

@article{SobrinoCosso2012ProtonPI, title={Proton pump inhibitors in gastroesophageal reflux disease: "a custom-tailored therapeutic regimen".}, author={Sergio Roberto Sobrino-Coss{\'i}o and Juan Carlos L{\'o}pez-Alvarenga and Jos{\'e} Mar{\'i}a Remes-Troche and Elymir Soraya Galvis-Garc{\'i}a and Julio C{\'e}sar Soto-P{\'e}rez and Oscar Teramoto-Matsubara and Miguel Morales-Ar{\'a}mbula and Antonio Orozco-G{\'a}miz and Jos{\'e} Luis Tamayo de-la-Cuesta and Gualberto Mateos and Arturo Jim{\'e}nez and Adolfo S{\'a}ez and Jos{\'e} Antonio Vargas}, journal={Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva}, year={2012}, volume={104 7}, pages={367-78} }